Guidelines and literature
Oncology and PET/CT Gallery
- 2019
Comparing the Staging/Restaging Performance of 68Ga-Labeled Prostate-Specific Membrane Antigen and 18F-Choline PET/CT in Prostate Cancer: A Systematic Review and Meta-analysis.
Lin, C. Y., Lee, M. T., Lin, C. L., & Kao, C. H. (2019). Comparing the Staging/Restaging Performance of 68Ga-Labeled Prostate-Specific Membrane Antigen and 18F-Choline PET/CT in Prostate Cancer: A Systematic Review and Meta-analysis. Clin Nucl Med, 44(5), 365-376. doi:10.1097/rlu.0000000000002526
- 2019
Correlation between PSA kinetics and PSMA-PET in prostate cancer restaging: A meta-analysis.
Pereira Mestre, R., Treglia, G., Ferrari, M., Pascale, M., Mazzara, C., Azinwi, N. C., . . . Roggero, E. (2019). Correlation between PSA kinetics and PSMA-PET in prostate cancer restaging: A meta-analysis. Eur J Clin Invest, 49(3), e13063. doi:10.1111/eci.13063
- 2019
Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis.
Kim, S. J., Pak, K., & Kim, K. (2019). Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis. Am J Otolaryngol, 40(2), 297-305. doi:10.1016/j.amjoto.2018.10.013
- 2019
Diagnostic accuracy of F18 flucholine PET/CT for preoperative lymph node staging in newly diagnosed prostate cancer patients; a systematic review and meta-analysis.
Kim, S. J., & Lee, S. W. (2019). Diagnostic accuracy of (F)18 flucholine PET/CT for preoperative lymph node staging in newly diagnosed prostate cancer patients; a systematic review and meta-analysis. Br J Radiol, 92(1101), 20190193. doi:10.1259/bjr.20190193
- 2019
Diagnostic and grading accuracy of 18F-FDOPA PET and PET/CT in patients with gliomas: a systematic review and meta-analysis.
Xiao, J., Jin, Y., Nie, J., Chen, F., & Ma, X. (2019). Diagnostic and grading accuracy of (18)F-FDOPA PET and PET/CT in patients with gliomas: a systematic review and meta-analysis. BMC Cancer, 19(1), 767. doi:10.1186/s12885-019-5938-0
- 2019
Diagnostic Performance and Prognostic Value of PET/CT with Different Tracers for Brain Tumors: A Systematic Review of Published Meta-Analyses.
Treglia, G., Muoio, B., Trevisi, G., Mattoli, M. V., Albano, D., Bertagna, F., & Giovanella, L. (2019). Diagnostic Performance and Prognostic Value of PET/CT with Different Tracers for Brain Tumors: A Systematic Review of Published Meta-Analyses. Int J Mol Sci, 20(19). doi:10.3390/ijms20194669
- 2019
Diagnostic performance of 18F-FDG-PET/CT in DTC patients with thyroglobulin elevation and negative iodine scintigraphy: a meta-analysis.
Qichang, W., Lin, B., Gege, Z., Youjia, Z., Qingjie, M., Renjie, W., & Bin, J. (2019). Diagnostic performance of 18F-FDG-PET/CT in DTC patients with thyroglobulin elevation and negative iodine scintigraphy: a meta-analysis. Eur J Endocrinol, 181(2), 93-102. doi:10.1530/eje-19-0261
- 2019
Diagnostic Performance of Radiolabeled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging in Newly Diagnosed Intermediate to High-Risk Prostate Cancer Patients: A Systematic Review and Meta-Analysis.
Kim, S. J., Lee, S. W., & Ha, H. K. (2019). Diagnostic Performance of Radiolabeled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging in Newly Diagnosed Intermediate to High-Risk Prostate Cancer Patients: A Systematic Review and Meta-Analysis. Urol Int, 102(1), 27-36. doi:10.1159/000493169
- 2019
Diagnostic performance of [18F]FDG-PET/MRI for liver metastasis in patients with primary malignancy: a systematic review and meta-analysis.
Hong, S. B., Choi, S. H., Kim, K. W., Park, S. H., Kim, S. Y., Lee, S. J., . . . Lee, M. G. (2019). Diagnostic performance of [(18)F]FDG-PET/MRI for liver metastasis in patients with primary malignancy: a systematic review and meta-analysis. Eur Radiol, 29(7), 3553-3563. doi:10.1007/s00330-018-5909-x
- 2019
FDG PET/CT for assessing tumour response to immunotherapy : Report on the EANM symposium on immune modulation and recent review of the literature.
Aide, N., Hicks, R. J., Le Tourneau, C., Lheureux, S., Fanti, S., & Lopci, E. (2019). FDG PET/CT for assessing tumour response to immunotherapy : Report on the EANM symposium on immune modulation and recent review of the literature. Eur J Nucl Med Mol Imaging, 46(1), 238-250. doi:10.1007/s00259-018-4171-4
- 2019
Imaging of Prostate Specific Membrane Antigen Targeted Radiotracers for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis.
Tan, N., Bavadian, N., Calais, J., Oyoyo, U., Kim, J., Turkbey, I. B., . . . Davenport, M. S. (2019). Imaging of Prostate Specific Membrane Antigen Targeted Radiotracers for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis. J Urol, 202(2), 231-240. doi:10.1097/ju.0000000000000198
- 2019
Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial
Konert, T. V., W. V.: Paez, D.: Polo, A.: Fidarova, E.: Carvalho, H.: Duarte, P. S.: Zuliani, A. C.: Santos, A. O.: Altuhhova, D.: Karusoo, L.: Kapoor, R.: Sood, A.: Khader, J.: Al-Ibraheem, A.: Numair, Y.: Abubaker, S.: Soydal, C.: Kutuk, T.: Le, T. A.: Canh, N. X.: Bieu, B. Q.: Ha, L. N.: Belderbos, J. S. A.: MacManus, M. P.: Thorwarth, D.: Hanna, G. G. (2019). Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial. Eur J Nucl Med Mol Imaging, 46(11), 2235-2243.
- 2019
Letter to the editor-in-chief of Head and Neck
Rubello, D. T., G.: Valdes Olmos, R.: Giammarile, F. (2019). Letter to the editor-in-chief of Head and Neck. Head Neck, 41(12), 4234-4235. doi:10.1002/hed.25902
- 2019
MRI combined with PET-CT of different tracers to improve the accuracy of glioma diagnosis: a systematic review and meta-analysis.
Yang, Y., He, M. Z., Li, T., & Yang, X. (2019). MRI combined with PET-CT of different tracers to improve the accuracy of glioma diagnosis: a systematic review and meta-analysis. Neurosurg Rev, 42(2), 185-195. doi:10.1007/s10143-017-0906-0
- 2019
Non-FDG PET/CT in Diagnostic Oncology: a pictorial review
Giammarile, F. C., Paolo: Dierckx, Rudi: Estrada Lobato, Enrique: Farsad, Mohsen: Hustinx, Roland: Jalilian, Amirreza: Pellet, Olivier: Rossi, Susana: Paez, Diana. (2019). Non-FDG PET/CT in Diagnostic Oncology: a pictorial review. European Journal of Hybrid Imaging, 3(1), 20. Retrieved from https://doi.org/10.1186/s41824-019-0066-2. doi:10.1186/s41824-019-0066-2
- 2019
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1.
Alongi, P., Laudicella, R., Desideri, I., Chiaravalloti, A., Borghetti, P., Quartuccio, N., . . . Fiorentino, A. (2019). Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1. Crit Rev Oncol Hematol, 140, 74-79. doi:10.1016/j.critrevonc.2019.01.011
- 2019
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study.
Quartuccio, N., Evangelista, L., Alongi, P., Caobelli, F., Altini, C., Cistaro, A., . . . Chiaravalloti, A. (2019). Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study. Nucl Med Commun, 40(8), 808-814. doi:10.1097/mnm.0000000000001038
- 2019
Prognostic value of 18F-FDG PET/CT functional parameters in patients with head and neck cancer: a meta-analysis.
Wang, L., Bai, J., & Duan, P. (2019). Prognostic value of 18F-FDG PET/CT functional parameters in patients with head and neck cancer: a meta-analysis. Nucl Med Commun, 40(4), 361-369. doi:10.1097/mnm.0000000000000974
- 2019
Prognostic value of metabolic tumour volume and total lesion glycolysis measured by 18F-fluorodeoxyglucose positron emission tomography/computed tomography in small cell lung cancer: A systematic review and meta-analysis.
Nie, K., Zhang, Y. X., Nie, W., Zhu, L., Chen, Y. N., Xiao, Y. X., . . . Yu, H. (2019). Prognostic value of metabolic tumour volume and total lesion glycolysis measured by 18F-fluorodeoxyglucose positron emission tomography/computed tomography in small cell lung cancer: A systematic review and meta-analysis. J Med Imaging Radiat Oncol, 63(1), 84-93. doi:10.1111/1754-9485.12805
- 2019
Response to Prof. Ingo Brink and Prof. Aubalewska-Dydejczyk regarding Their "Letter to the Editor"
Sundin, A. F., S.: Giammarile, F.: de Herder, W. W. (2019). Response to Prof. Ingo Brink and Prof. Aubalewska-Dydejczyk regarding Their "Letter to the Editor". Neuroendocrinology, 108(4), 366. doi:10.1159/000497419
- ‹ previous
- 3 of 11
- next ›